<code id='320A4983D8'></code><style id='320A4983D8'></style>
    • <acronym id='320A4983D8'></acronym>
      <center id='320A4983D8'><center id='320A4983D8'><tfoot id='320A4983D8'></tfoot></center><abbr id='320A4983D8'><dir id='320A4983D8'><tfoot id='320A4983D8'></tfoot><noframes id='320A4983D8'>

    • <optgroup id='320A4983D8'><strike id='320A4983D8'><sup id='320A4983D8'></sup></strike><code id='320A4983D8'></code></optgroup>
        1. <b id='320A4983D8'><label id='320A4983D8'><select id='320A4983D8'><dt id='320A4983D8'><span id='320A4983D8'></span></dt></select></label></b><u id='320A4983D8'></u>
          <i id='320A4983D8'><strike id='320A4983D8'><tt id='320A4983D8'><pre id='320A4983D8'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:Wikipedia    Page View:8
          Pharmacy shelves
          A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter. GEORGE FREY/AFP via Getty Images

          WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than $1 million on lobbying last quarter — its highest-ever spend by far, according to federal filings.

          The Council for Citizens Against Government Waste spent $1.1 million on lobbying last quarter, and only employed a single lobbyist. That’s 22 times the $50,000 it spent in the same quarter last year. Its prior spending record was $700,000, from the start of 2020.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Alnylam reports growth in sales of rare disease treatments
          Alnylam reports growth in sales of rare disease treatments

          KristofferTripplaar/SipaUSA/APAlnylamPharmaceuticalssaidThursdaythatsalesofitstreatmentsforraredisea

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Personalized medicine goes far beyond genetics

          AdobeSincetheHumanGenomeProjectwascompletedin2003,mostpublicconsiderationsofpersonalizedmedicinehave